Home
Herriot Tabuteau, CEO: Axsome Therapeutics AXSM Sell · Filed 25/09/16
Trade details
- Type
- Insider sale
- Amount
- $3,319,816.72
- Shares · price
- 27,907 sh · $118.96 a share
- Held after
- 7,229 sh
- Person
- Herriot TabuteauCEO
- Trade date
- 25/09/12
- Filed
- 25/09/16
- Days to filing
- 4 days
Sold 79.4% of holdings
- Share of holding sold
- 79.4%
Axsome Therapeutics trades, last 26 weeks
What else happened in Axsome Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/13~25/10/12Herriot Tabuteau's recent trades
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$979.2K
4,660 sh
$979.2K
Filed 08/06
Traded 08/06
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$9.6M
45,004 sh
$9.6M
Filed 08/05
Traded 08/05
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$12M
49,666 sh
$12M
Filed 07/01
Traded 07/01
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$12.2M
49,670 sh
$12.2M
Filed 06/09
Traded 06/09
- Herriot Tabuteau
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 planAxsome Therapeutics
AXSM
$12M
49,670 sh
$12M
Filed 06/09
Traded 06/09